Ravichandran R, Lafferty F, McGinniss M J, Taylor H C
Division of Endocrinology, Health Cleveland, Ohio 44113, USA.
J Clin Endocrinol Metab. 1996 May;81(5):1776-9. doi: 10.1210/jcem.81.5.8626833.
Divergent recommendations exist regarding the evaluation of adrenal incidentalomas. Recent data have indicated a prevalence of adrenal tumors of 71% in nonclassical congenital adrenal hyperplasia (CAH) and unmasked heterozygotes. These data expand the differential diagnosis of such incidental tumors and substantially modify the approach to their evaluation. We present two patients, female pseudohermaphrodites with the simple virilizing form of CAH and 21-hydroxylase deficiency, who functioned successfully as married phenotypic males. Both came to medical attention in the sixth decade by virtue of massive adrenal incidentalomas encountered in the evaluation of recurrent urinary tract infections. Each had a 46, XX karyotype, no palpable testes, and markedly elevated baseline levels of 17-hydroxyprogesterone (17-OH Prog) of 6086 ng/dL and 6750 ng/dL. Both responded appropriately to dexamethasone suppression with reduction of 17-OH Prog, androgens and, in the second patient, ACTH to normal or near normal levels. Histologic and autopsy examination of the first patient's tumor and computed tomographic characteristics of the second revealed a benign adenoma and myelolipoma respectively. We extend and confirm previous recommendations that CAH be included in the differential diagnosis of adrenal incidentaloma and that baseline 17-OH Prog. levels be obtained, with ACTH stimulation if necessary, to diagnose the presence of nonclassical CAH.
关于肾上腺偶发瘤的评估,存在不同的建议。近期数据表明,在非经典型先天性肾上腺皮质增生症(CAH)和未被发现的杂合子中,肾上腺肿瘤的患病率为71%。这些数据扩展了此类偶发肿瘤的鉴别诊断范围,并显著改变了对其评估的方法。我们报告了两名患者,她们是患有单纯男性化型CAH和21-羟化酶缺乏症的女性假两性畸形患者,作为已婚表型男性,她们的生活很成功。两人均在60多岁时因在评估复发性尿路感染时发现巨大肾上腺偶发瘤而就医。两人的核型均为46, XX,未触及睾丸,17-羟孕酮(17-OH Prog)的基线水平显著升高,分别为6086 ng/dL和6750 ng/dL。两人对地塞米松抑制试验反应良好,17-OH Prog、雄激素水平降低,第二例患者的促肾上腺皮质激素(ACTH)降至正常或接近正常水平。对第一例患者的肿瘤进行组织学和尸检检查,对第二例患者进行计算机断层扫描特征分析,结果分别显示为良性腺瘤和髓脂瘤。我们扩展并确认了先前的建议,即CAH应纳入肾上腺偶发瘤的鉴别诊断中,应检测基线17-OH Prog水平,必要时进行ACTH刺激试验,以诊断非经典型CAH的存在。